ICUI

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 16

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,875

F14 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $300.20 to $301.20, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 15

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,169

SEC source: 0001189727-18-000010 · edgardoc.xml · derivative · entry 20

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,145

Underlying: Common Stock · 34,747 shares

Expires 2024-02-24

F17 · price: Transaction is the exercise of a derivative security; see Column 2.

F16 · derivative.exercise_date: Options exercisable in four equal annual cumulative installments commencing one year after the grant date.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 14

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F13 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.13 to $302.40, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 13

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,274

F12 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.10 to $302.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 12

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,247

F11 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.55, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 11

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,747

SEC source: 0001189727-18-000010 · edgardoc.xml · derivative · entry 19

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,892

Underlying: Common Stock · 17,108 shares

Expires 2024-02-24

F17 · price: Transaction is the exercise of a derivative security; see Column 2.

F16 · derivative.exercise_date: Options exercisable in four equal annual cumulative installments commencing one year after the grant date.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 10

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F10 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $304.15 to $305.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 9

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,197

F9 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $303.10 to $304.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 8

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,174

F8 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.05 to $303.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 7

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,909

F7 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.00 to $302.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 6

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,108

F6 · kind: Shares were previously acquired through the Registrant's Employee Stock Purchase Plan.

F5 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 5

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,299

F1 · security: These securities are Restricted Stock Units.

F5 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 4

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,399

F1 · security: These securities are Restricted Stock Units.

F4 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $304.60 to $304.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 3

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,811

F1 · security: These securities are Restricted Stock Units.

F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $303.55 to $304.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 2

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,611

F1 · security: These securities are Restricted Stock Units.

F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.50 to $303.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 1

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,311

SEC source: 0001073398-18-000011 · edgardoc.xml · derivative · entry 5

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,500 shares

Expires 2018-10-20

F3 · derivative.exercise_date: Options exercisable in four equal annual cumulative installments commencing one year after the grant date.

SEC source: 0001073398-18-000011 · edgardoc.xml · derivative · entry 4

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,500 shares

Expires 2018-07-21

F3 · derivative.exercise_date: Options exercisable in four equal annual cumulative installments commencing one year after the grant date.

SEC source: 0001073398-18-000011 · edgardoc.xml · nonDerivative · entry 2

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,040

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2018.

F2 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001073398-18-000011 · edgardoc.xml · nonDerivative · entry 1

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,383

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 11

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 395,716

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F12 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $292.60 to $293.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 10

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 397,095

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F11 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $291.50 to $292.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 9

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 402,688

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F10 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $290.45 to $291.35, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 8

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 404,988

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F9 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $292.88 to $293.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 7

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 405,813

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F8 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $291.85 to $292.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 6

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 410,782

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F7 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $290.80 to $291.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 5

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416,116

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F6 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $296.65 to $296.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 4

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416,216

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F5 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $295.15 to $296.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 3

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416,416

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F4 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $293.85 to $294.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 2

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 417,385

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $292.75 to $293.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 426,016

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $291.70 to $292.70, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000012 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 428,648

F1 · price: Shares transferred as a bona fide gift without any consideration.

SEC source: 0001698998-18-000004 · edgardoc.xml · nonDerivative · entry 1

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $273.65 to $273.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001410442-18-000011 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,143

F1 · price: Shares transferred as a bona fide gift without any consideration.

SEC source: 0001669639-18-000006 · edgardoc.xml · nonDerivative · entry 1

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 617

F1 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001209191-18-031036 · doc4.xml · derivative · entry 2

FINNEY ELISHA W · CIK 0001217439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,163

Underlying: Common Stock · 1,163 shares

Expires 2028-05-15

SEC source: 0001209191-18-031036 · doc4.xml · derivative · entry 1

FINNEY ELISHA W · CIK 0001217439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315

Underlying: Common Stock · 315 shares

Expires 2019-05-15

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award.

SEC source: 0001209191-18-031056 · doc4.xml · derivative · entry 2

Hoffmeister David F · CIK 0001305975 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,163

Underlying: Common Stock · 1,163 shares

Expires 2028-05-15

SEC source: 0001209191-18-031056 · doc4.xml · derivative · entry 1

Hoffmeister David F · CIK 0001305975 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315

Underlying: Common Stock · 315 shares

Expires 2019-05-15

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award.

SEC source: 0001209191-18-031017 · doc4.xml · derivative · entry 2

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,163

Underlying: Common Stock · 1,163 shares

Expires 2028-05-15

SEC source: 0001209191-18-031017 · doc4.xml · derivative · entry 1

Abbey Donald · CIK 0001534342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315

Underlying: Common Stock · 315 shares

Expires 2019-05-15

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award.

SEC source: 0001645866-18-000004 · edgardoc.xml · derivative · entry 2

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,163

Underlying: Common Stock · 1,163 shares

Expires 2028-05-15

SEC source: 0001645866-18-000004 · edgardoc.xml · derivative · entry 1

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315

Underlying: Common Stock · 315 shares

Expires 2019-05-15

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award.

SEC source: 0001073398-18-000009 · edgardoc.xml · derivative · entry 2

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,163

Underlying: Common Stock · 1,163 shares

Expires 2028-05-15

SEC source: 0001073398-18-000009 · edgardoc.xml · derivative · entry 1

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315

Underlying: Common Stock · 315 shares

Expires 2019-05-15

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award.

SEC source: 0001190251-18-000005 · edgardoc.xml · nonDerivative · entry 1

SAUCEDO JOSEPH R · CIK 0001190251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $269.00 to $269.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 18

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 428,716

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F12 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 17

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 428,816

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F18 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $257.15 to $258.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.